These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28693376)

  • 1. Ibrutinib-induced acute liver failure.
    Kahn A; Horsley-Silva JL; Lam-Himlin DM; Reeder CB; Douglas DD; Carey EJ
    Leuk Lymphoma; 2018 Feb; 59(2):512-514. PubMed ID: 28693376
    [No Abstract]   [Full Text] [Related]  

  • 2. ibrutinib (IMBRUVICA°) and Waldenström's macroglobulinaemia.
    Prescrire Int; 2016 Oct; 25(175):232. PubMed ID: 30645823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sudden ventricular fibrillation and death during ibrutinib therapy-A case report.
    Bernardeschi P; Pirrotta MT; Del Rosso A; Fontanelli G; Milandri C
    Eur J Haematol; 2019 Oct; 103(4):442-443. PubMed ID: 31287200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fungal infections in patients treated with ibrutinib: two unusual cases of invasive aspergillosis and cryptococcal meningoencephalitis.
    Baron M; Zini JM; Challan Belval T; Vignon M; Denis B; Alanio A; Malphettes M
    Leuk Lymphoma; 2017 Dec; 58(12):2981-2982. PubMed ID: 28554246
    [No Abstract]   [Full Text] [Related]  

  • 5. Ibrutinib discontinuation in Waldenström macroglobulinemia: Etiologies, outcomes, and IgM rebound.
    Gustine JN; Meid K; Dubeau T; Severns P; Hunter ZR; Guang Y; Xu L; Treon SP; Castillo JJ
    Am J Hematol; 2018 Aug; 93(4):511-517. PubMed ID: 29280186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ibrutinib therapy for lymphoplasmacytic lymphoma.
    Helber MJ; Moore JE; Williams AM; Meacham PJ; Rothberg PG; Zent CS
    Am J Hematol; 2017 Sep; 92(9):E542-E544. PubMed ID: 28543765
    [No Abstract]   [Full Text] [Related]  

  • 7. CXCL13 levels are elevated in patients with Waldenström macroglobulinemia, and are predictive of major response to ibrutinib.
    Vos JM; Tsakmaklis N; Patterson CJ; Meid K; Castillo JJ; Brodsky P; Ganz T; Pals ST; Kersten MJ; Xu L; Yang G; Treon SP; Hunter ZR
    Haematologica; 2017 Nov; 102(11):e452-e455. PubMed ID: 28798070
    [No Abstract]   [Full Text] [Related]  

  • 8. Ibrutinib withdrawal symptoms in patients with Waldenström macroglobulinemia.
    Castillo JJ; Gustine JN; Meid K; Dubeau T; Severns P; Treon SP
    Haematologica; 2018 Jul; 103(7):e307-e310. PubMed ID: 29472352
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of ibrutinib in the treatment of Bing-Neel syndrome.
    Cabannes-Hamy A; Lemal R; Goldwirt L; Poulain S; Amorim S; Pérignon R; Berger J; Brice P; De Kerviler E; Bay JO; Sauvageon H; Beldjord K; Mourah S; Tournilhac O; Thieblemont C
    Am J Hematol; 2016 Mar; 91(3):E17-9. PubMed ID: 26689870
    [No Abstract]   [Full Text] [Related]  

  • 10. Resolution of Waldenström Macroglobulinemia-Associated Autoimmune Hemolysis With Ibrutinib.
    Tripathi A; Steingart R
    J Oncol Pract; 2016 May; 12(5):490-1. PubMed ID: 27170696
    [No Abstract]   [Full Text] [Related]  

  • 11. Ibrutinib for the treatment of Bing-Neel syndrome, a complication of Waldenström macroglobulinemia: Patient case report.
    Hartsell L; Janes A; Larck C; Park S; Arnall JR
    J Oncol Pharm Pract; 2019 Sep; 25(6):1534-1539. PubMed ID: 30760164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ibrutinib-associated hemophagocytic lymphohistiocytosis: A case series from Johns Hopkins.
    Ambinder AJ; Hambley B; Shanbhag S; Merrill SA
    Am J Hematol; 2019 Nov; 94(11):E296-E299. PubMed ID: 31400009
    [No Abstract]   [Full Text] [Related]  

  • 13. Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomes.
    Abeykoon JP; Zanwar S; Ansell SM; Gertz MA; Kumar S; Manske M; Novak AJ; King R; Greipp P; Go R; Inwards D; Muchtar E; Habermann T; Witzig TE; Thompson CA; Dingli D; Lacy MQ; Leung N; Dispenzieri A; Gonsalves W; Warsame R; Kyle RA; Rajkumar V; Parikh SA; Kapoor P
    Br J Haematol; 2020 Feb; 188(3):394-403. PubMed ID: 31468508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ibrutinib is Effective in Refractory Type II Cryoglobulinemia.
    Barot SV; Lee SS; Patel BJ; Valent JN
    Clin Lymphoma Myeloma Leuk; 2019 Dec; 19(12):e629-e632. PubMed ID: 31585822
    [No Abstract]   [Full Text] [Related]  

  • 15. Ibrutinib in the management of Waldenstrom macroglobulinemia.
    Yosef A; Touloukian EZ; Nambudiri VE
    J Oncol Pharm Pract; 2019 Mar; 25(2):434-441. PubMed ID: 29996737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid flare of immune thrombocytopenia after stopping ibrutinib in a patient with chronic lymphocytic leukemia.
    Sato R; Jacob J; Gaballa S
    Leuk Lymphoma; 2018 Jul; 59(7):1738-1741. PubMed ID: 29081253
    [No Abstract]   [Full Text] [Related]  

  • 17. The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19-infected patients.
    Treon SP; Castillo JJ; Skarbnik AP; Soumerai JD; Ghobrial IM; Guerrera ML; Meid K; Yang G
    Blood; 2020 May; 135(21):1912-1915. PubMed ID: 32302379
    [No Abstract]   [Full Text] [Related]  

  • 18. A head-to-head Phase III study comparing zanubrutinib versus ibrutinib in patients with Waldenström macroglobulinemia.
    Tam CS; LeBlond V; Novotny W; Owen RG; Tedeschi A; Atwal S; Cohen A; Huang J; Buske C
    Future Oncol; 2018 Sep; 14(22):2229-2237. PubMed ID: 29869556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ibrutinib for the Management of Schnitzler Syndrome: A Novel Therapy for a Rare Condition.
    Jani P; Vissing MB; Ahmed S; Sluzevich JC; Aulakh S; Alegria V; Ailawadhi M; Chanan-Khan A; Ailawadhi S
    J Oncol Pract; 2018 Jun; 14(6):387-388. PubMed ID: 29558252
    [No Abstract]   [Full Text] [Related]  

  • 20. Ibrutinib is an effective treatment for B-cell prolymphocytic leukaemia.
    Gordon MJ; Raess PW; Young K; Spurgeon SEF; Danilov AV
    Br J Haematol; 2017 Nov; 179(3):501-503. PubMed ID: 27391978
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.